GNOM vs VTA

Global X Genomics & Biotechnology ETF

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

Invesco Credit Opportunities Fund

Invesco Dynamic Credit Opportunities Fund is a close-ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc., Invesco Asset Management Deutschland GmbH, Invesco Asset Management Limited, Invesco Asset Management (Japan) Limited, Invesco Hong Kong Limited, Invesco Senior Secured Management, Inc., and Invesco Canada Ltd. It invests in the fixed income markets across the globe with a focus on the United States. The fund invests in securities of companies that operate across diversified sectors. It invests in fixed income securities such as senior secured floating rate loans, fixed rate loans, and collateralized debt. The fund employs fundamental analysis with a bottom-up security selection process to create its portfolio. It conducts in-house research to make its investments. The fund benchmarks the performance of its portfolio against the Credit Suisse Leveraged Loan Index. It was formerly known as Invesco Van Kampen Dynamic Credit Opportunities Fund. Invesco Dynamic Credit Opportunities Fund was formed on June 26, 2007 and is domiciled in the United States.